|
Market Cap (4-Jun) $10,198,677 (1,598th) |
Close (30-Jun) $0.024 |
Volume (30-Jun) 2,170,184 |
Shortsold (2-Feb) 3,141 (0.00%) (662nd) |
|
52w High $0.008 |
52w Low $0.002 |
P/E - |
EPS 0 |
1AD released this announcement to the ASX on 11 February 2022, 9:10. The announcement is not marked as price sensitive, and is 13 page(s) in length and 370.17kb in size.
You can view all announcements from 1AD and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from 1AD | |
|---|---|
| AD-214 clinical trial approval | 29 June 2023, 8:21 |
| Change in substantial holding | 31 May 2023, 13:30 |
| Change in substantial holding | 31 May 2023, 9:34 |
| Change in Director Interest Notice x 4 | 11 February 2022, 9:10 |
| Application for quotation of securities - 1AD | 7 February 2022, 8:28 |
| Entitlement Offer Results | 3 February 2022, 10:51 |
| Quarterly Appendix 4C and Activities Report | 24 January 2022, 8:44 |
You must be logged in to post a reply.
AdAlta 